In Reply to ‘The US Renal Data System “Pie Chart of Death”’

Slides:

Advertisements

Similar presentations

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.

Advertisements

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.

2016 Annual Data Report, Vol 2, ESRD, Ch 5

Figure 9.1 Causes of death in ESRD patients,

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

2016 Annual Data Report, Vol 2, ESRD, Ch 6

John W. Pickering, PhD, Matthew T. James, MD, PhD, FRCPC, Suetonia C

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Organ Trafficking: Global Solutions for a Global Problem

Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.

Volume 2: End-Stage Renal Disease

Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.

Renal Function Testing

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Lilia Cervantes, Monica Grafals, Rudolph A. Rodriguez

Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD

Peter A. McCullough, MD, MPH, Timothy Larsen, DO, Jeremiah R

Peritoneal dialysis American Journal of Kidney Diseases

In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’ Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.

Volume 2: End-Stage Renal Disease

Susan P.Y. Wong, MD, Ann M. O'Hare, MD, MA

Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H

Care of the Undocumented Immigrant in the United States With ESRD

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

The US Renal Data System “Pie Chart of Death”

The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective Gregorio T. Obrador, MD, MPH, Ximena Rubilar,

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Recognition for Conservative Care in Kidney Failure

Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Evaluation of the Potential Living Kidney Donor

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Wayne Trebbin, MD, Peter Monteleone, MD

Guidelines for the Older Adult With CKD

Lifetime Incidence of CKD Stages 3-5 in the United States

Cerebrovascular Disease Incidence, Characteristics, and Outcomes in Patients Initiating Dialysis: The Choices for Healthy Outcomes in Caring for ESRD.

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Dorothea Nitsch, MD, MSc American Journal of Kidney Diseases

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Management of Heart Failure in Advancing CKD: Core Curriculum 2018

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and Controversies Krista L. Lentine, MD, MS, Frank P. Hurst,

Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A

A Timely Evaluation of the Psychometric Properties of the KDQOL-36

American Journal of Kidney Diseases

Organ Trafficking: Global Solutions for a Global Problem

Study Designs in Patient-Oriented Research

Dennis G. Moledina, MD, Mark A. Perazella, MD

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test Study Anneke P. Bech,

Risk for Incident Renal Dialysis in a Managed Care Population

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Kidney Failure Treatment: The Freedom to Choose

August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Supportive care for patients with renal disease: Time for action

Decongestive Treatment of Acute Decompensated Heart Failure: Cardiorenal Implications of Ultrafiltration and Diuretics Benjamin J. Freda, DO, Mara Slawsky,

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Comparison of 2 Acute Renal Failure Severity Scores to General Scoring Systems in the Critically Ill Annika Åhlström, MD, Anne Kuitunen, MD, PhD, Seija.

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

Figure 9.1.a Causes of death in ESRD patients,

Presentation transcript:

In Reply to ‘The US Renal Data System “Pie Chart of Death”’ Brahmajee K. Nallamothu, MD, MPH, Peter Song, PhD, Rajiv Saran, MD, MS, MRCP American Journal of Kidney Diseases Volume 68, Issue 6, (December 2016) DOI: 10.1053/j.ajkd.2016.08.016 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Causes of death in dialysis patients 2011 to 2013, including missing/unknown causes. This alternate pie chart differs from the analysis provided in the original 2015 US Renal Data System Annual Data Report3 (see Fig 1A of Herzog et al1 for a rendering), in which the denominator included other causes of death and excluded missing/unknown causes of death (23.5% of patients had unknown or missing causes of death). Alternate pie chart based on special analyses using Reference Table H12 related to Fig 9.1 [volume 2] of Saran et al.3 “Unknown causes” includes records from the Centers for Medicare & Medicaid Services 2746 end-stage renal disease (ESRD) death notification form that specifically designate an “unknown” cause of death. “Missing” includes records in the ESRD database that are missing form 2746 or have the form but are missing or have recording errors in the primary cause of death field. The denominator of this alternate pie chart includes other known causes, unknown causes of death, and records that are missing the cause of death. Abbreviations: AHD, atherosclerotic heart disease; AMI, acute myocardial infarction; CHF, congestive heart failure; CVA, cerebrovascular accident. American Journal of Kidney Diseases 2016 68, DOI: (10.1053/j.ajkd.2016.08.016) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions